Pharvaris Stock (NASDAQ:PHVS), Quotes and News Summary

Q: What sector and industry does Pharvaris (PHVS) operate in?

Pharvaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Pharvaris Stock (NASDAQ: PHVS) stock price, news, charts, stock research, profile.

Open	$22.360
Close	$20.850
Volume / Avg.	27.497K / 83.401K
Day Range	20.590 - 22.575
52 Wk Range	7.930 - 33.000
Market Cap	$1.224B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	0.22%
Days to Cover	1.42

Recent News

FDA Clears Pharvaris' Trial For Investigational Drug For Swollen Blood Vessels, Stock Jumps

Pharvaris receives FDA approval to advance deucrictibant for hereditary angioedema prophylaxis, lifting clinical hold. Learn about the latest developments in HAE treatment.

Vandana Singh

Gold Moves Higher; Campbell Soup Earnings Top Expectations

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.

Lisa Levin

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Pharvaris (PHVS) stock?

You can purchase shares of Pharvaris (NASDAQ: PHVS) through any online brokerage.

View our list of the best stock brokerages.

Who are Pharvaris's (PHVS) competitors?

There are no as such competitors for Pharvaris.

What is the target price for Pharvaris (PHVS) stock?

The latest price target for Pharvaris (NASDAQ: PHVS) was reported by Morgan Stanley on Monday, April 22, 2024. The analyst firm set a price target for 34.00 expecting PHVS to rise to within 12 months (a possible 49.45% upside). 20 analyst firms have reported ratings in the last year.

Current Stock Price for Pharvaris (PHVS)?

The stock price for Pharvaris (NASDAQ: PHVS) is $22.75 last updated May 7, 2024 at 4:04 PM EDT.

Does Pharvaris (PHVS) pay a dividend?

There are no upcoming dividends for Pharvaris.

When is Pharvaris (NASDAQ:PHVS) reporting earnings?

Pharvaris’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is Pharvaris (PHVS) going to split?

There is no upcoming split for Pharvaris.

What sector and industry does Pharvaris (PHVS) operate in?

Pharvaris is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.